Wealthfront Advisers’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $272K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $843K | Sell |
|
|||||
|
2024
Q3 | $1.61M | Sell |
|
|||||
|
2024
Q2 | $1.82M | Sell |
|
|||||
|
2024
Q1 | $2.49M | Sell |
|
|||||
|
2023
Q4 | $2.24M | Buy |
|
|||||
|
2023
Q3 | $270K | Buy |
|
|||||
|
2023
Q2 | $247K | Sell |
|
|||||
|
2023
Q1 | $364K | Sell |
|
|||||
|
2022
Q4 | $465K | Buy |
|
|||||
|
2022
Q3 | $364K | Buy |
|
|||||
|
2022
Q2 | $296K | Buy |
|
|||||
|
2022
Q1 | $298K | Sell |
|
|||||
|
2021
Q4 | $1.96M | Buy |
|
|||||
|
2021
Q3 | $1.29M | Buy |
|
|||||
|
2021
Q2 | $373K | Buy |
|
|||||
|
2021
Q1 | $245K | Buy |
|